Notch signaling promotes survival and recurrence of dormant mammary tumor cells following HER2/neu targeted therapy

被引：0
|
作者：
Abravanel, Daniel L. [1 ]
Collins, Meredith A. [1 ]
Belka, George K. [1 ]
Pan, Tien-chi [1 ]
Pant, Dhruv K. [1 ]
Sterner, Christopher J. [1 ]
Chodosh, Lewis A. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2894
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2894
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy
    Abravanel, Daniel L.
    Belka, George K.
    Pan, Tien-chi
    Pant, Dhruv K.
    Collins, Meredith A.
    Sterner, Christopher J.
    Chodosh, Lewis A.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (06): : 2484 - 2496
  • [2] Notch signaling regulates recurrence in a model of HER2 targeted therapy
    Abravanel, Daniel L.
    Sterner, Christopher J.
    Pan, Tien-chi
    Belka, George K.
    Chodosh, Lewis A.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [3] Her2/Neu Receptor Signaling in Rat and Human Prolactinoma Cells: Novel Strategy for Targeted Prolactinoma Therapy
    Fukuoka, H.
    Vlotides, G.
    Cooper, O.
    Mizutani, J.
    Ren, S.
    Melmed, S.
    [J]. ENDOCRINE REVIEWS, 2010, 31 (03) : S2526 - S2526
  • [4] Role of HER2/neu in tumor progession and therapy
    Ménard, S
    Casalini, P
    Campiglio, M
    Pupa, SM
    Tagliabue, E
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (23) : 2965 - 2978
  • [5] Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors
    Hardee, Matthew E.
    Eapen, Rose J.
    Rabbani, Zahid N.
    Dreher, Matthew R.
    Marks, Jeffrey
    Blackwell, Kimberly L.
    Dewhirst, Mark W.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (02) : 219 - 228
  • [6] Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors
    Matthew E. Hardee
    Rose J. Eapen
    Zahid N. Rabbani
    Matthew R. Dreher
    Jeffrey Marks
    Kimberly L. Blackwell
    Mark W. Dewhirst
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 63 : 219 - 228
  • [7] Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
    Castiello, Luciano
    Sestili, Paola
    Schiavoni, Giovanna
    Dattilo, Rosanna
    Monque, Domenica M.
    Ciaffoni, Fiorella
    Iezzi, Manuela
    Lamolinara, Alessia
    Sistigu, Antonella
    Moschella, Federica
    Pacca, Anna Maria
    Macchia, Daniele
    Ferrantini, Maria
    Zeuner, Ann
    Biffoni, Mauro
    Proietti, Enrico
    Belardelli, Filippo
    Arico, Eleonora
    [J]. CANCER IMMUNOLOGY RESEARCH, 2018, 6 (06) : 658 - 670
  • [8] Targeted Therapy in Metastatic Breast Cancer: The HER2/neu Oncogene
    Harbeck, Nadia
    Pegram, Mark D.
    Rueschoff, Josef
    Moebus, Volker
    [J]. BREAST CARE, 2010, 5 : 3 - 7
  • [9] HER2 isoforms in mammary carcinogenesis and targeted therapy susceptibility
    Palladini, A.
    Dall'Ora, M.
    Grosso, V.
    Ianzano, M. L.
    Ranieri, D.
    Balboni, T.
    Iezzi, M.
    De Giovanni, C.
    Lollini, P. L.
    Nanni, P.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : S158 - S158
  • [10] Engineering of Escherichia coli for Targeted Delivery of Transgenes to HER2/neu-Positive Tumor Cells
    Chang, Chih-Hsiang
    Cheng, Wei-Jou
    Chen, Shan-Yu
    Kao, Ming-Ching
    Chiang, Chung-Jen
    Chao, Yun-Peng
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2011, 108 (07) : 1662 - 1672
12345